Invert Bio Analysis: $500K Raised
What is Invert Bio?
Invert provides software for bioprocess development and manufacturing teams. The platform connects instruments and data sources, structures experimental data, and applies AI to bioprocess workflows. The company reports quantified customer outcomes such as 3,046 hours saved per program and a close-to-go-live timeframe under one month.
Location
San Francisco, United States
Employees
11-50
Founded
2021
Business Model
Subscription-based software services for bioprocess data management and analytics.
Product Features & Capabilities
- Integrations, Data Management, Analysis, Modeling, Metric Management, Lineage, Pre-built Models
Pricing
- Invert Bio does not offer generic pricing or plans.
- Pricing is tailored to specific needs and implementation requirements.
- Clients are encouraged to fill out a form to explore pricing options.
How much Invert Bio raised
1: - $500K
January 28, 2022Lead Investor: Y Combinator
Market Focus
Invert Bio primarily focuses on the biotechnology industry, specifically providing software solutions for managing, analyzing, and modeling bioprocess data.
Investors
- Giant Ventures
- Y Combinator
- EIC Accelerator
- imec.istart future fund
- Enterprise Ireland
- BGF
Competitors Overview
Invert Bio's main competitors in the bioprocess data management software market include:
-
New Wave Biotech: This company focuses on developing bioprocess optimization software aimed at enhancing research and development, particularly in scaling precision fermentation from lab to production. Their emphasis on bioprocess optimization may provide advantages for users specifically looking to improve efficiency in fermentation processes.
-
Benchling: A cloud-based platform that offers a comprehensive suite of software tools designed to streamline various aspects of biotechnology research and development. Benchling's extensive toolset may provide a broader range of functionalities compared to Invert Bio, catering to diverse needs in biotech R&D.
Notable differences include New Wave Biotech's specific focus on bioprocess optimization and Benchling's comprehensive approach to biotech research, which may appeal to different segments of the market depending on user requirements.
See something that needs updating? Suggest edits to this profile.